Global Biologics Safety Testing Market Growth (Status and Outlook) 2023-2029

Global Biologics Safety Testing Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Biologics Safety Testing Industry Forecast” looks at past sales and reviews total world Biologics Safety Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Biologics Safety Testing sales for 2023 through 2029. With Biologics Safety Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologics Safety Testing industry.

This Insight Report provides a comprehensive analysis of the global Biologics Safety Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biologics Safety Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biologics Safety Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologics Safety Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologics Safety Testing.

The global Biologics Safety Testing market size is projected to grow from US$ 2413.8 million in 2022 to US$ 3935.9 million in 2029; it is expected to grow at a CAGR of 7.2% from 2023 to 2029.

Biologics are advanced drugs used in treatment of cancer, rheumatoid arthritis, and other diseases. These biologics constitutes large molecules such as monoclonal antibodies, recombinant proteins and their safety ensures patient safety as these are used in the treatment of different diseases.

This report presents a comprehensive overview, market shares, and growth opportunities of Biologics Safety Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Endotoxin Tests
Sterility Tests
Cell Line Authentication and Characterization Tests
Bioburden Tests
Cell Line Authentication
Residual Host Contaminant Detection Tests
Adventitious Agent Detection Tests
Others

Segmentation by application
Pharmaceutical
Medical Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lonza Group
Charles River
Merck
SGS
WuXi AppTec
Thermo Fisher Scientific
Sartorius
Cytovance Biologics
Pace Analytical Services
Toxikon

Please note: The report will take approximately 2 business days to prepare and deliver.